Xiang-wei Kong
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Whole-Exome Profiling of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma of the Nasopharynx.
Journal: Endocrine pathology
Published: October 22, 2025
Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion.
Journal: Nature communications
Published: July 14, 2024
Design and characterization of defined alpha-helix mini-proteins with intrinsic cell permeability.
Journal: Computational biology and chemistry
Published: April 12, 2024
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinoma.
Journal: The Journal of clinical investigation
Published: April 03, 2024
Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection.
Journal: Cell reports. Medicine
Published: October 18, 2023
mRNA-based Vaccines Targeting the T-cell Epitope-rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti-Tumor Immunity in Mice.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 01, 2023
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV.
Journal: Cell host & microbe
Published: January 02, 2023
Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses.
Journal: Journal of virology
Published: April 11, 2022
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants.
Journal: Signal transduction and targeted therapy
Published: January 01, 2022
Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Journal: mSphere
Published: December 03, 2020
Last Updated: 09/26/2026